The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 2 trial of dovitinib in Bacillus Calmette-Guerin (BCG) refractory urothelial carcinoma (UC) with tumor FGFR3 mutations or over-expression: Hoosier Cancer Research Network GU12-157.
 
Noah M. Hahn
Honoraria - D3 Oncology Solutions
Consulting or Advisory Role - AstraZeneca/MedImmune; Bristol-Myers Squibb; Medivation; Merck; Oncogenex
Research Funding - Abbott Laboratories (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Dendreon (Inst); Genentech/Roche (Inst); Merck (Inst); Merck (Inst); Millennium (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Novartis (Inst); Oncogenex (Inst); Sanofi (Inst)
 
Trinity J. Bivalacqua
Speakers' Bureau - Photocure
Research Funding - Heat Biologics (Inst); Photocure (Inst)
 
Ashley Ross
No Relationships to Disclose
 
George J. Netto
No Relationships to Disclose
 
Jong Chul Park
No Relationships to Disclose
 
Timothy A. Masterson
No Relationships to Disclose
 
Michael O. Koch
No Relationships to Disclose
 
Richard Bihrle
No Relationships to Disclose
 
Richard Foster
No Relationships to Disclose
 
Thomas A. Gardner
No Relationships to Disclose
 
Liang Cheng
No Relationships to Disclose
 
David R Jones
No Relationships to Disclose
 
Kyle McElyea
No Relationships to Disclose
 
George Sandusky
No Relationships to Disclose
 
Ziyue Liu
No Relationships to Disclose
 
Scott A Turner
No Relationships to Disclose
 
Gregory J. Tsongalis
No Relationships to Disclose
 
Elizabeth R. Plimack
Consulting or Advisory Role - Acceleron Pharma; Bristol-Myers Squibb; Dendreon; Genentech/Roche; GlaxoSmithKline; Merck; Novartis; Pfizer
Research Funding - Acceleron Pharma (Inst); Acerta Pharma (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Dendreon (Inst); GlaxoSmithKline (Inst); Lilly (Inst); Merck (Inst); Pfizer (Inst)
Patents, Royalties, Other Intellectual Property - U.S. Patent No.: 14/588,503, Filed 1/2/2015. (Inst)
 
Richard E. Greenberg
No Relationships to Disclose
 
Daniel M. Geynisman
Consulting or Advisory Role - Novartis; Pfizer; Prometheus
Research Funding - Pfizer (Inst)
Travel, Accommodations, Expenses - Novartis; Pfizer; Prometheus